| EU/1/18/1266/006 |
7683C |
Steglujan 5 mg/100 mg filmom obalené tablety |
tbl flm 90x5 mg/100 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
23.03.2023 |
| EU/1/18/1266/005 |
7682C |
Steglujan 5 mg/100 mg filmom obalené tablety |
tbl flm 84x5 mg/100 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
23.03.2023 |
| EU/1/18/1266/004 |
7681C |
Steglujan 5 mg/100 mg filmom obalené tablety |
tbl flm 30x1x5 mg/100 mg (blis.Al/PVC/PA/Al-jednotk.bal.) |
MSD-NL |
23.03.2023 |
| EU/1/18/1266/003 |
7680C |
Steglujan 5 mg/100 mg filmom obalené tablety |
tbl flm 30x5 mg/100 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
23.03.2023 |
| EU/1/18/1266/002 |
7679C |
Steglujan 5 mg/100 mg filmom obalené tablety |
tbl flm 28x5 mg/100 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
23.03.2023 |
| EU/1/18/1266/001 |
7678C |
Steglujan 5 mg/100 mg filmom obalené tablety |
tbl flm 14x5 mg/100 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
23.03.2023 |
| EU/1/18/1267/014 |
8924C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 98x15 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/013 |
8923C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 98x5 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/07/436/007 |
5639C |
ISENTRESS 600 mg filmom obalené tablety |
tbl flm 180(3x60)x600 mg (f?.HDPE - multibal.) |
MSD-NL |
|
| EU/1/18/1267/012 |
7677C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 90x15 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/011 |
7676C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 84x15 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/010 |
7675C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 30x1x15 mg (blis.Al/PVC/PA/Al-jednotk.bal.) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/009 |
7674C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 30x15 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/008 |
7673C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 28x15 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/007 |
7672C |
Steglatro 15 mg filmom obalené tablety |
tbl flm 14x15 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/006 |
7671C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 90x5 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/005 |
7670C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 84x5 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/004 |
7669C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 30x1x5 mg (blis.Al/PVC/PA/Al-jednotk.bal.) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/003 |
7668C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 30x5 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/002 |
7667C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 28x5 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/18/1267/001 |
7666C |
Steglatro 5 mg filmom obalené tablety |
tbl flm 14x5 mg (blis.Al/PVC/PA/Al) |
MSD-NL |
21.03.2023 |
| EU/1/16/1156/001 |
3039C |
ZINPLAVA 25 mg/ml koncentrát na infúzny roztok |
con inf 1x40 ml/1000 mg (liek.inj.skl.) |
MSD-NL |
18.01.2022 |
| EU/1/99/127/053 |
7335B |
IntronA 25 miliónov IU/2,5 ml injek?ný alebo infúzny roztok |
sol ijf 12x2,5 ml/25 MU (12xliek.inj.skl.+72 striek.inj.) |
MSD-NL |
|
| EU/1/99/127/052 |
7334B |
IntronA 25 miliónov IU/2,5 ml injek?ný alebo infúzny roztok |
sol ijf 2x2,5 ml/25 MU (2xliek.inj.skl.+12 striek.inj.) |
MSD-NL |
|
| EU/1/99/127/051 |
7333B |
IntronA 25 miliónov IU/2,5 ml injek?ný alebo infúzny roztok |
sol ijf 1x2,5 ml/25 MU (liek.inj.skl.+6 striek.inj.) |
MSD-NL |
|
| EU/1/99/127/050 |
7332B |
IntronA 25 miliónov IU/2,5 ml injek?ný alebo infúzny roztok |
sol ijf 12x2,5 ml/25 MU (12xliek.inj.skl.+72 striek.inj.s bezp.zar.) |
MSD-NL |
|
| EU/1/99/127/049 |
7331B |
IntronA 25 miliónov IU/2,5 ml injek?ný alebo infúzny roztok |
sol ijf 2x2,5 ml/25 MU (2xliek.inj.skl.+12 striek.inj.s bezp.zar.) |
MSD-NL |
|
| EU/1/99/127/048 |
7330B |
IntronA 25 miliónov IU/2,5 ml injek?ný alebo infúzny roztok |
sol ijf 1x2,5 ml/25 MU (liek.inj.skl.+6 striek.inj.s bezp.zar.) |
MSD-NL |
|
| EU/1/99/127/047 |
7329B |
IntronA 18 miliónov IU/3 ml injek?ný alebo infúzny roztok |
sol ijf 12x3 ml/18 MU (12xliek.inj.skl.+72 striek.inj.s bezp.zar.) |
MSD-NL |
|
| EU/1/99/127/046 |
7328B |
IntronA 18 miliónov IU/3 ml injek?ný alebo infúzny roztok |
sol ijf 2x3 ml/18 MU (2xliek.inj.skl.+12 striek.inj.s bezp.zar.) |
MSD-NL |
|
| EU/1/99/127/045 |
7327B |
IntronA 18 miliónov IU/3 ml injek?ný alebo infúzny roztok |
sol ijf 1x3 ml/18 MU (liek.inj.skl.+6 striek.inj.s bezp.zar.) |
MSD-NL |
|
| EU/1/07/436/006 |
4741C |
ISENTRESS 600 mg filmom obalené tablety |
tbl flm 60x600 mg (f?.HDPE) |
MSD-NL |
|
| EU/1/15/1032/001 |
5963B |
Zerbaxa 1 g/ 0,5 g prášok na prípravu infúzneho koncentrátu |
plc ifc 10x1g/0,5 g (liek.inj.skl.) |
MSD-NL |
18.09.2020 |
| EU/1/03/262/011 |
7992B |
EMEND 125 mg prášok na perorálnu suspenziu |
plu por 1x125 mg (vre.PET/Al/LLDPE) |
MSD-NL |
|
| EU/1/17/1245/004 |
6846C |
PREVYMIS 480 mg koncentrát na infúzny roztok |
con inf 1x24 ml/480 mg (liek.inj.skl.) |
MSD-NL |
08.01.2023 |
| EU/1/17/1245/003 |
6845C |
PREVYMIS 240 mg koncentrát na infúzny roztok |
con inf 1x12 ml/240 mg (liek.inj.skl.) |
MSD-NL |
08.01.2023 |
| EU/1/17/1245/002 |
6844C |
PREVYMIS 480 mg filmom obalené tablety |
tbl flm 28x1x480 mg (blis.Al/Al-jednotk.dávka) |
MSD-NL |
08.01.2023 |
| EU/1/17/1245/001 |
6843C |
PREVYMIS 240 mg filmom obalené tablety |
tbl flm 28x1x240 mg (blis.Al/Al-jednotk.dávka) |
MSD-NL |
08.01.2023 |
| EU/1/15/991/003 |
4098B |
Sivextro 200 mg prášok na prípravu infúzneho koncentrátu |
plc ifc 6x200 mg (liek.inj.skl.) |
MSD-NL |
23.03.2020 |
| EU/1/15/991/002 |
4097B |
Sivextro 200 mg prášok na prípravu infúzneho koncentrátu |
plc ifc 1x200 mg (liek.inj.skl.) |
MSD-NL |
23.03.2020 |
| EU/1/15/991/001 |
4092B |
Sivextro 200 mg filmom obalené tablety |
tbl flm 6x1x200 mg (blis.PVC/PVDC/Al-perf.) |
MSD-NL |
23.03.2020 |
| EU/1/10/621/024 |
3696B |
Ristaben 100 mg filmom obalené tablety |
tbl flm 90x100 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/10/621/023 |
3695B |
Ristaben 100 mg filmom obalené tablety |
tbl flm 30x100 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/10/621/022 |
3694B |
Ristaben 50 mg filmom obalené tablety |
tbl flm 90x50 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/10/621/021 |
3693B |
Ristaben 50 mg filmom obalené tablety |
tbl flm 30x50 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/10/621/020 |
3692B |
Ristaben 25 mg filmom obalené tablety |
tbl flm 90x25 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/10/621/019 |
3691B |
Ristaben 25 mg filmom obalené tablety |
tbl flm 30x25 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/08/456/022 |
3690B |
Velmetia 50 mg/1000 mg filmom obalené tablety |
tbl flm 180x50 mg/1000 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/08/456/021 |
3689B |
Velmetia 50 mg/1000 mg filmom obalené tablety |
tbl flm 60x50 mg/1000 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
| EU/1/08/456/020 |
3688B |
Velmetia 50 mg/850 mg filmom obalené tablety |
tbl flm 180x50 mg/850 mg (blis.PVC/PE/PVDC/Al) |
MSD-NL |
|
